Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients

被引：0
|
作者：
Diana Carmona-Fernandes
Maria José Santos
Inês Pedro Perpétuo
João Eurico Fonseca
Helena Canhão
机构：
[1] Instituto de Medicina Molecular,Rheumatology Research Unit
[2] Faculdade de Medicina da Universidade de Lisboa,Rheumatology Department
[3] Edifício Egas Moniz,Rheumatology and Bone Metabolic Diseases Department
[4] Hospital Garcia de Orta,undefined
[5] Hospital de Santa Maria,undefined
来源：
Arthritis Research & Therapy | / 13卷
关键词：
sRANKL; osteoprotegerin; systemic lupus erythematosus; osteoclastogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
    Pacifico, Lucia
    Andreoli, Gian Marco
    D'Avanzo, Miriam
    De Mitri, Delia
    Pierimarchi, Pasquale
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (19) : 2073 - 2082
  • [32] Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
    Lucia Pacifico
    Gian Marco Andreoli
    Miriam D'Avanzo
    Delia De Mitri
    Pasquale Pierimarchi
    World Journal of Gastroenterology, 2018, 24 (19) : 2073 - 2082
  • [33] Expression profiles of receptor activator of nuclear factor κB ligand, receptor activator of nuclear factor κB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones
    Ikeda, T
    Utsuyama, M
    Hirokawa, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (08) : 1416 - 1425
  • [34] Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus
    Her, M.
    Kim, D.
    Oh, M.
    Jeong, H.
    Choi, I.
    LUPUS, 2009, 18 (06) : 501 - 507
  • [35] STUDY OF SERUM OSTEOPROTEGERIN AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND IN PATIENTS WITH RHEUMATIC DISEASES
    Geneva-Popova, Mariela
    Popova, Stanislava
    JOURNAL OF IMAB, 2021, 27 (04): : 4170 - 4177
  • [36] Soluble Receptor Activator of Nuclear Factor-κB Ligand (sRANKL)/Osteoprotegerin Balance in Ageing and Age-Associated Diseases
    Lia Pulsatelli
    Paolo Dolzani
    Tania Silvestri
    Paolo Caraceni
    Andrea Facchini
    Giovanni Ravaglia
    Carlo Salvarani
    Riccardo Melicòni
    Erminia Mariani
    Biogerontology, 2004, 5 : 119 - 127
  • [37] Effect of Breastfeeding on Serum Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Full Term Neonates
    Rafeey, Mandana
    Ghorbanihaghjo, Amir
    Masoumi, Fardad
    Alizadeh, Samira
    Farid, Sina Davari
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2013, 15 (10)
  • [38] Soluble receptor activator of nuclear factor-κB ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases
    Pulsatelli, L
    Dolzani, P
    Silvestri, T
    Caraceni, P
    Facchini, A
    Ravaglia, G
    Salvarani, C
    Meliconi, R
    Mariani, E
    BIOGERONTOLOGY, 2004, 5 (02) : 119 - 127
  • [39] Osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in the serum of healthy adults
    Jung, K
    Lein, M
    Von Hösslin, K
    Grosse, A
    Roth, S
    Possinger, K
    Lüftner, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 177 - 181
  • [40] Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation
    Chen, Chun-Hsiung
    Chen, Hung-An
    Liao, Hsien-Tzung
    Liu, Chin-Hsiu
    Tsai, Chang-Youh
    Chou, Chung-Tei
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1155 - 1161
12345